pre-IPO PHARMA

kernal-biologics PRESS RELEASE ARCHIVE

Jul 7, 2022

Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology


Nov 9, 2021

Kernal Biologics Presenting Results at the 9th Annual mRNA Health Conference


Jul 22, 2021

Kernal Biologics Enters Development Phase Reaching Critical Milestones for its First mRNA-Based Cancer-Therapeutic Product


Google Analytics Alternative